November 30, 2011. Dr. Diana Zuckerman, the president of NRC, provided a statement for the Senate Aging Committees regarding problems with antipsychotic drugs.
Read More »On Medical Treatments & Products
NCHR Testimony at the FDA Advisory Committee Meeting on Breast Implants
October 24, 2011. Dana Casciotti, NCHR Public Health Research Director, testifies at an FDA advisory meeting on breast implants.
Read More »NCHR Testimony at FDA Advisory Meeting on Breast Implants
September 24, 2011. NRC President, Dr. Diana Zuckerman testifies at an FDA advisory hearing on breast implants.
Read More »NCHR Testimony at the FDA on Transvaginal Mesh
September 8, 2011. National Research Center of Women & Families Brandel France de Bravo testifies at the FDA meeting on transvaginal mesh.
Read More »NCHR Testimony on Transvaginal Mesh
September 9, 2011. We agree with the FDA that serious adverse events from mesh are NOT rare. No man or woman wants to suffer from incontinence, but there is no doubt that the terribly painful complications can be much worse than the incontinence that initially led to surgery. And, those complications are often impossible to repair.
Read More »